MedTrace Logo

Effect of Enhanced External Counterpulsation (EECP) on Subclinical Atherosclerosis

NCT01106495 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2020-11-02

No results posted yet for this study

Summary

Shear stress maybe the most crucial local factor affecting atherogenesis. The present study investigated the effect of exposure to increased shear stress promoted by Enhanced External Counterpulsation (EECP) on the progression of subclinical atherosclerosis and the underlying inflammation- related molecular mechanisms

Conditions

Interventions

DEVICE

Enhanced External Counterpulsation (EECP)

EECP one hour per day, 5 hours a week for a total of 35- 36 hours over a 7 week period

DRUG

Simvastatin

Simvastatin 40 mg/d for 7 weeks as the guideline- driven standard medical treatment

Sponsors & Collaborators

  • Sun Yat-sen University

    lead OTHER

Principal Investigators

  • Hong Ma, MD · First Affiliated Hospital, Sun Yat-Sen University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-05-31
Primary Completion
2018-10-31
Completion
2020-01-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01106495 on ClinicalTrials.gov